Literature DB >> 24716910

MiR-421, miR-155 and miR-650: emerging trends of regulation of cancer and apoptosis.

Ammad Ahmad Farooqi1, Muhammad Zahid Qureshi, Ender Coskunpinar, Syed Kamran-Ul-Hassan Naqvi, Ilhan Yaylim, Muhammad Ismail.   

Abstract

It is becoming progressively more understandable that between transcription and translation there lies another versatile regulator that quantitatively controls the expression of mRNAs. Identification of miRNAs as key regulators of wide ranging signaling cascades and modulators of different cell-type and context dependent activities attracted basic and clinical scientists to study modes and mechanisms in details. In line with this approach overwhelmingly increasing in vivo and in vitro studies are deepening our understanding regarding miR-421, mir-155 and miR-650 mediated regulation of cellular activities. We also attempt to provide an overview of long non coding RNAs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24716910     DOI: 10.7314/apjcp.2014.15.5.1909

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.

Authors:  Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Paola Lucia Chiara Iervolino; Esther Imperlini; Annalisa Mandola; Anna Verde; Anna Elisa De Stefano; Katia Pane; Monica Franzese; Silvia Esposito; Fulvio Basolo; Stefania Orrù; Giuliana Salvatore
Journal:  Endocrine       Date:  2019-03-29       Impact factor: 3.633

2.  Essential role of microRNA-650 in the regulation of B-cell CLL/lymphoma 11B gene expression following transplantation: A novel mechanism behind the acute rejection of renal allografts.

Authors:  Peng Jin; Hongxi Chen; Jinliang Xie; Cheng Zhou; Xiangrong Zhu
Journal:  Int J Mol Med       Date:  2017-10-17       Impact factor: 4.101

3.  Radiation-induced circulating miRNA expression in blood of head and neck cancer patients.

Authors:  Francesca Pasi; Franco Corbella; Ambrogia Baio; Enrica Capelli; Annalisa De Silvestri; Carmine Tinelli; Rosanna Nano
Journal:  Radiat Environ Biophys       Date:  2020-02-10       Impact factor: 1.925

4.  Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells.

Authors:  Lixia Lv; Xiumei An; Hongyan Li; Lanxiu Ma
Journal:  Oncol Lett       Date:  2015-12-03       Impact factor: 2.967

5.  Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.

Authors:  Yan-Li Qu; Hai-Feng Wang; Zhen-Qiang Sun; Yong Tang; Xiao-Na Han; Xian-Bo Yu; Kun Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.

Authors:  Zhaozhou Ren; Ming He; Tao Shen; Kejia Wang; Qingjie Meng; Xiangxu Chen; Long Zhou; Yanshuo Han; Chao Ji; Shengnan Liu; Qin Fu
Journal:  Cancer Biol Ther       Date:  2019-11-12       Impact factor: 4.742

Review 7.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

8.  Interactive cooperation and hierarchical operation of microRNA and transcription factor crosstalk in human transcriptional regulatory network.

Authors:  Esra Gov; Kazim Yalcin Arga
Journal:  IET Syst Biol       Date:  2016-12       Impact factor: 1.615

9.  Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice.

Authors:  Lei Song; Zhongrui Zhang; Jinling Zhang; Xuebin Zhu; Lei He; Zhe Shi; Li Gao; Fumin Feng
Journal:  Exp Ther Med       Date:  2016-05-20       Impact factor: 2.447

10.  Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study.

Authors:  Stefano Di Carlo; Elena Rossi; Gianfranco Politano; Simona Inghilleri; Patrizia Morbini; Fiorella Calabrese; Alfredo Benso; Alessandro Savino; Emanuela Cova; Davide Zampieri; Federica Meloni
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.